Export

EN
FR
Budesonide + formoterol
Essential medicine status
Section:
25. Medicines acting on the respiratory tract 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease
ATC codes: R03AK07
Indication
Asthma ICD11 code: CA23
INN
Budesonide + formoterol
Medicine type
Chemical agent
List type
Core
Formulations
Respiratory > Inhalation > dry powder: 100 µg + 6 µg per dose ; 200 µg + 6 µg per dose
EML status history
First added in 2017 (TRS 1006)
Changed in 2021 (TRS 1035)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
budesonide + salmeterol (ATC codes: R03AK12)
beclometasone + formoterol (ATC codes: R03AK08)
mometasone + formoterol (ATC codes: R03AK09)
fluticasone + formoterol (ATC codes: R03AK11)
fluticasone furoate + vilanterol (ATC codes: R03AK10)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Budesonide + formoterol
DrugBank
Budesonide ,
Formoterol
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended the following be specified as therapeutic alternatives under the square box listing for budesonide + formoterol for treatment of asthma on the EML: beclometasone + formoterol, budesonide + salmeterol, fluticasone + formoterol, fluticasone furoate + vilanterol, and mometasone + formoterol.